Latest France News

Little Green Pharma reported a robust 40% revenue increase for FY25, driven by strong European sales and the strategic acquisition of Health House. The company also advanced clinical research and secured new therapy funding, positioning itself for continued growth.

Gas2Grid Limited moves closer to securing a new service contract in the Philippines while appealing a significant legal claim in France, all under the pressure of an impending ASX suspension deadline.

Titomic Limited advances its strategic U.S. footprint with a new Huntsville facility set to open in June 2025, securing major defense collaborations and expanding commercial momentum in additive manufacturing.

Apollo Minerals reports completion of Phase 2 drilling at its Salanie Gold Project with promising high-grade results, alongside strategic funding and ongoing exploration in Gabon, Serbia, and France.

Medical Developments International reported a robust Q3 FY25 with $8.9 million revenue and $1.7 million operating cashflow, driven by strong Penthrox demand and pricing. New distribution agreements in France and Switzerland position the company for further European expansion.

BrainChip Holdings advanced its neuromorphic AI technology through significant contracts with the Swedish National Space Agency and the U.S. Air Force, while exploring a potential redomiciling to the US. The company reported steady cash outflows and ongoing strategic partnerships.

Cochlear Limited posted a 6% increase in HY25 sales revenue driven by strong implant sales but anticipates FY25 profits at the lower end of guidance due to declining services revenue and rising cloud investments.

Cochlear Limited has reported a robust half-year performance with a 7% increase in underlying net profit and an 8% rise in interim dividends, driven by strong sales in cochlear and acoustic implants despite a decline in services revenue.

Treasury Wine Estates has delivered a robust half-year performance with revenue climbing nearly 20% and profit surging 33%, driven by premiumisation and strategic acquisitions. The company also declared a higher interim dividend, signaling confidence in its growth trajectory.

CLINUVEL has released preliminary data from its CUV052 study showing SCENESSE® is well tolerated in adolescent erythropoietic protoporphyria (EPP) patients, supporting a planned label extension in 2025.

Atlas Arteria reveals it will face a significant temporary supplemental tax under France’s new 2025 Finance Law, impacting its APRR Group operations with payments due late next year.

Domino's Pizza Enterprises signals a strategic reset with the closure of 205 underperforming stores, primarily in Japan, aiming to sharpen focus and improve profitability while maintaining steady earnings guidance.